Drug Database
Back to search

Switzerland· 66810002

Topotecan Accord 4 mg, Konzentrat zur Herstellung einer Infusionslösung

A topotecan product containing topotecanum, registered in Switzerland by Accord Healthcare AG and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC L01CE01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedTopotecan Accord 4 mg, Konzentrat zur…ATCL01CE01REGISTER NO.66810002PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about topotecanumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Topotecan is registered in 15 of 19 countries.

Countries holding a registration under ATC L01CE01 (topotecan), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 9 of them publish a price we can compare per daily dose
Search topotecan products by name

Topotecan · ATC L01CE01

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of topotecan costs, country by country.

Normalised to the WHO defined daily dose (1 mg), so markets compare like for like.

  • Switzerland: $80.29 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Topotecan · price per daily dose (1 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$80.29
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
topotecanum
Manufacturer
Accord Healthcare AG
Country
Switzerland (CH)
ATC code
L01CE01
ATC class
Topotecan
Defined daily dose
1 mg, O
Swissmedic category
A
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680668100026
    Durchstf 1 Stk
    CHF 280.55

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

348 interactions on record for topotecan.

Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check topotecan against other medicinesHow interaction checks work

Topotecan · interactions on record

348 records

  • 31 severe
  • 277 moderate
  • 16 minor
  • 24 info

Most severe, free to view

  • CisplatinL01XA01severe
  • CarboplatinL01XA02severe
  • OxaliplatinL01XA03severe
  • RolapitantA04AD14moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Topotecan in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All topotecan products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Topotecan Accord, Topotecan Ebewe
  • Belgium · Topotecan Accord Healthcare
  • Bulgaria · Топотекан Акорд
  • Cyprus · Topotecan Accord, Topotecan Venus
  • Czechia · Topotecan Accord
  • Germany · Topotecan Accord, Topotecan Hexal
  • Denmark · Topotecan "ebewe", Topotecan Accord
  • Estonia · Topotecan Accord
  • Spain · Topotecán Accord
  • Finland · Topotecan Accord, Topotecan Ebewe
  • France · Topotecane Accord
  • United Kingdom (Northern Ireland) · Topotecan Accord Healthcare, Topotecan Sandoz
  • Greece · Topocan, Topotecan Accord
  • Croatia · Topotekan Alpha-Medical
  • Hungary · Topotecan Accord
  • Ireland · Topotecan Accord
  • Iceland · Hycamtin, Potactasol
  • Italy · Topotecan Ahcl
  • Liechtenstein · Hycamtin, Hycamtin 4 Mg Powder For Concentrate For Solution For Infusion
  • Lithuania · Topotecan Accord
  • Luxembourg · Topotecan Accord Healthcare
  • Latvia · Topotecan Ahcl
  • Netherlands · Topotecan Accord, Topotecan Hikma
  • Norway · Hycamtin, Potactasol
  • Poland · Topotecanum Accord
  • Portugal · Topotecano Accord, Topotecano Azevedos
  • Romania · Topotecan Accord
  • Sweden · Topotecan Accord, Topotecan Ebewe
  • Slovenia · Topotekan Accord
  • Slovakia · Topotecan Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d82e35f0-55c6-4d5b-9f93-89a675619514
GET /v1/drugs/d82e35f0-55c6-4d5b-9f93-89a675619514?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "topotecanum 4 mg",
  "valid_from": "2019-07-01",
  "limitations": "[{\"description\":\"Second-Line Therapie des kleinzelligen Bronchialkarzinoms bei Versagen oder Rezidiv nach primärer Chemotherapie mit einem aktuell etablierten Schema.<br>\\nBehandlung des metastasierenden Ovarialkarzinoms nach fehlendem Erfolg der Primär- oder Folgetherapie.<br>\\nBehandlung in Kombination mit Cisplatin von Patientinnen mit histologisch bestätigtem, rezidivierendem, persistentem oder Stadium IV-B-Zervixkarzinom, wenn eine Behandlung mittels Operation und/oder Strahlentherapie nicht in Frage kommt.<br>\\n<br>\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2019-07-01\"}]",
  "galenic_form": "Inf Konz 4 mg/4ml",
  "therapeutic_area": null,
  "sl_inclusion_date": "2019-07-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about topotecan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console